{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:34:20Z","timestamp":1774262060791,"version":"3.50.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[2009,6,27]],"date-time":"2009-06-27T00:00:00Z","timestamp":1246060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s12016-009-8162-x","type":"journal-article","created":{"date-parts":[[2009,6,26]],"date-time":"2009-06-26T01:29:32Z","timestamp":1245979772000},"page":"307-318","source":"Crossref","is-referenced-by-count":36,"title":["Intravenous Immunoglobulin in Lupus Panniculitis"],"prefix":"10.1007","volume":"38","author":[{"given":"Jo\u00e3o","family":"Esp\u00edrito Santo","sequence":"first","affiliation":[]},{"given":"M. F.","family":"Gomes","sequence":"additional","affiliation":[]},{"given":"M. J.","family":"Gomes","sequence":"additional","affiliation":[]},{"given":"L.","family":"Peixoto","sequence":"additional","affiliation":[]},{"given":"S.","family":"C. Pereira","sequence":"additional","affiliation":[]},{"given":"A.","family":"Acabado","sequence":"additional","affiliation":[]},{"given":"J.","family":"Freitas","sequence":"additional","affiliation":[]},{"given":"G. Vinhas","family":"de Sousa","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2009,6,27]]},"reference":[{"key":"8162_CR1","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271\u20131277","journal-title":"Arthritis Rheum"},{"key":"8162_CR2","first-page":"6","volume":"22","author":"SE Ullrich","year":"2000","unstructured":"Ullrich SE (2000) Sun exposure and the lupus patient. Lupus Awareness 22:6\u20137","journal-title":"Lupus Awareness"},{"key":"8162_CR3","first-page":"89","volume":"18","author":"LM Vila","year":"1999","unstructured":"Vila LM, Mayor AM, Valentin AH et al (1999) Association of sunlight exposure and photoprotection measures with clinical outcome in systemic lupus erythematosus. Puerto Rico Health Sci J 18:89\u201394","journal-title":"Puerto Rico Health Sci J"},{"key":"8162_CR4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/096120339600500404","volume":"5","author":"A Doria","year":"1996","unstructured":"Doria A et al (1996) Photosensitivity in systemic lupus erythematosus: laboratory testing of ARA\/ACR definition. Lupus 5:263\u2013268","journal-title":"Lupus"},{"key":"8162_CR5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00005792-198509000-00001","volume":"64","author":"MC Hochberg","year":"1985","unstructured":"Hochberg MC et al (1985) Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine 64:285\u2013295","journal-title":"Medicine"},{"key":"8162_CR6","first-page":"53","volume":"7","author":"MF Mikle","year":"1996","unstructured":"Mikle MF, Barton EN, Morgan OS, Deceulaer K (1996) Photosensitivity and antinuclear antibodies in black patients with systemic lupus erythematosus. J Assoc Acad Minor Phys 7:53\u201355","journal-title":"J Assoc Acad Minor Phys"},{"key":"8162_CR7","doi-asserted-by":"crossref","first-page":"664","DOI":"10.7326\/0003-4819-97-5-664","volume":"97","author":"RD Sontheimer","year":"1982","unstructured":"Sontheimer RD et al (1982) Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med 97:664\u2013671","journal-title":"Ann Intern Med"},{"key":"8162_CR8","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/art.1780310811","volume":"31","author":"JP Callen","year":"1988","unstructured":"Callen JP, Klein J (1988) Subacute cutaneous lupus erythematosus. Clinical, serologic, immunogenetic, and therapeutic considerations in seventy two patients. Arthritis Rheum 31:1007\u20131013","journal-title":"Arthritis Rheum"},{"key":"8162_CR9","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0190-9622(88)70272-8","volume":"19","author":"C Herrero","year":"1988","unstructured":"Herrero C et al (1988) Subacute cutaneous lupus erythematosus: clinicopathologic findings in thirteen cases. J Am Acad Dermatol 19:1057\u20131062","journal-title":"J Am Acad Dermatol"},{"key":"8162_CR10","first-page":"1","volume-title":"Cutaneous manifestations of rheumatic diseases","author":"RD Sontheimer","year":"1996","unstructured":"Sontheimer RD, Provost TT (1996) Lupus erythematosus. In: Sontheimer RD, Provost TT (eds) Cutaneous manifestations of rheumatic diseases. Williams and Wilkins, Baltimore, pp 1\u201371"},{"key":"8162_CR11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/archderm.1971.04000150001001","volume":"103","author":"DL Tuffanelli","year":"1971","unstructured":"Tuffanelli DL (1971) Lupus erythematosus panniculitis (profundus). Arch Dermatol 103:231\u2013242","journal-title":"Arch Dermatol"},{"key":"8162_CR12","first-page":"399","volume-title":"Immunopathology of the skin","author":"TT Provost","year":"1979","unstructured":"Provost TT (1979) Lupus band test. In: Beutner EH, Chorzelski TP, Bean SF (eds) Immunopathology of the skin, vol 22. Wiley, New York, pp 399\u2013410"},{"key":"8162_CR13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/archderm.1971.04000130026003","volume":"103","author":"TK Burnham","year":"1971","unstructured":"Burnham TK, Fine G (1971) The immunofluorescent \u201cband\u201d test for lupus erythematosus. III. Employing clinically normal skin. Arch Derm 103:24\u201332","journal-title":"Arch Derm"},{"key":"8162_CR14","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1191\/096120399678841007","volume":"8","author":"Y Levy","year":"1999","unstructured":"Levy Y, Sherer Y, Ahmed A, Langevitz P, George J, Fabbrizzi F, Terryberry J, Meissner M, Lorber M, Peter JB, Shoenfeld Y (1999) A study of 20 SLE patients with intravenous immunoglobulin clinical and serologic response. Lupus 8:705","journal-title":"Lupus"},{"issue":"2","key":"8162_CR15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5070\/D38F30C7RD","volume":"7","author":"BE Strober","year":"2001","unstructured":"Strober BE (2001) Lupus panniculitis (lupus profundus). Dermatology Online Journal 7(2):20 New York University, Department of Dermatology","journal-title":"Dermatology Online Journal"},{"key":"8162_CR16","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.1525-1470.2003.20210.x","volume":"20","author":"MB Wimmershoff","year":"2003","unstructured":"Wimmershoff MB, Hohenleutner U, Landthaler M (2003) Discoid lupus erythematosus and lupus profundus in childhood: a report of two cases. Pediatr Dermatol 20:140\u2013145","journal-title":"Pediatr Dermatol"},{"key":"8162_CR17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1191\/0961203305lu2088cr","volume":"14","author":"A Bacanli","year":"2005","unstructured":"Bacanli A, Uzun S, Ciftcioglu MA, Alpsoy E (2005) A case of lupus erythematosus profundus with unusual manifestations. Lupus 14:403","journal-title":"Lupus"},{"key":"8162_CR18","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/ndt\/14.4.966","volume":"14","author":"MT Chen","year":"1999","unstructured":"Chen MT, Chen KS, Chen MJ et al (1999) Lupus profundus (panniculitis) in a chronic haemodialysis patient. Nephrol Dial Transplant 14:966\u2013968","journal-title":"Nephrol Dial Transplant"},{"key":"8162_CR19","first-page":"68","volume":"26","author":"PB Martens","year":"1999","unstructured":"Martens PB, Moder KG, Ahmed I (1999) Lupus panniculitis: clinical perspectives from a case series. J Rheumatol 26:68\u201372","journal-title":"J Rheumatol"},{"key":"8162_CR20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000245706","volume":"195","author":"TM Kundig","year":"1997","unstructured":"Kundig TM, Trueb RM, Krasovec M (1997) Lupus profundus=panniculitis. Dermatology 195:99\u2013101","journal-title":"Dermatology"},{"key":"8162_CR21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2133.1996.tb07850.x","volume":"134","author":"T Watanabe","year":"1996","unstructured":"Watanabe T, Tsuchida T (1996) Lupus erythematosus profundus: a cutaneous marker for a distinct clinical subset? Br J Dermatol 134:123\u2013125","journal-title":"Br J Dermatol"},{"key":"8162_CR22","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1046\/j.1365-4362.2002.01510.x","volume":"41","author":"PP Ng","year":"2002","unstructured":"Ng PP, Tan SH, Tan T (2002) Lupus erythematosus panniculitis: a clinicopathologic study. Int J Dermatol 41:488\u2013490","journal-title":"Int J Dermatol"},{"key":"8162_CR23","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1191\/096120301678416105","volume":"10","author":"E Grossberg","year":"2001","unstructured":"Grossberg E, Scherschun L, Fiven DP (2001) Lupus profundus: not a benign disease. Lupus 10:514","journal-title":"Lupus"},{"key":"8162_CR24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0190-9622(93)70192-V","volume":"29","author":"SS Cernea","year":"1993","unstructured":"Cernea SS, Kihara SM, Sotto MN et al (1993) Lupus mastitis. J Am Acad Dermatol 29:343\u2013346","journal-title":"J Am Acad Dermatol"},{"key":"8162_CR25","first-page":"344","volume":"22","author":"NW Holland","year":"1995","unstructured":"Holland NW, McKnight K, Challa VR et al (1995) Lupus panniculitis (profundus) involving the breast: report of 2 cases and review of the literature. J Rheumatol 22:344\u2013346","journal-title":"J Rheumatol"},{"key":"8162_CR26","first-page":"535","volume":"117","author":"WL White","year":"1993","unstructured":"White WL, Sherertz EF, Berg D et al (1993) Periparotid lupus erythematosus panniculitis: clinicopathologic correlation of two cases presenting as primary parotid disease. Arch Pathol Lab Med 117:535\u2013539","journal-title":"Arch Pathol Lab Med"},{"key":"8162_CR27","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/096120339700600512","volume":"6","author":"N Ogura","year":"1997","unstructured":"Ogura N, Fujisaku A, Jodo S et al (1997) Lupus erythematosus profundus around the salivary glands: a case resembling submandibular gland disease. Lupus 6:477\u2013479","journal-title":"Lupus"},{"key":"8162_CR28","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0025-7125(16)30622-8","volume":"73","author":"MS Peters","year":"1989","unstructured":"Peters MS, Su WP (1989) Lupus erythematosus panniculitis. Med Clin North Am 73:1113\u20131126","journal-title":"Med Clin North Am"},{"key":"8162_CR29","first-page":"641","volume":"13","author":"SD Laman","year":"1994","unstructured":"Laman SD, Provost TT (1994) Cutaneous manifestations of lupus erythematosus. Rheum Dis Clin North Am 13:641\u2013644","journal-title":"Rheum Dis Clin North Am"},{"key":"8162_CR30","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0190-9622(91)70136-P","volume":"24","author":"J Tada","year":"1991","unstructured":"Tada J, Arata J, Katayama H (1991) Linear lupus erythematosus profundus in a child. J Am Acad Dermatol 24:871\u2013874","journal-title":"J Am Acad Dermatol"},{"key":"8162_CR31","first-page":"69","volume":"8","author":"E Heid","year":"1998","unstructured":"Heid E (1998) A 17-year old Italian boy with a linear lupus erythematosus profundus. Eur J Dermatol 8:69","journal-title":"Eur J Dermatol"},{"key":"8162_CR32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2230.1994.tb01125.x","volume":"19","author":"J Stork","year":"1994","unstructured":"Stork J, Vosmik F (1994) Lupus erythematosus panniculitis with morphea-like lesions. Clin Exp Dermatol 19:79\u201382","journal-title":"Clin Exp Dermatol"},{"key":"8162_CR33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0190-9622(92)70194-K","volume":"27","author":"P Hytiroglou","year":"1992","unstructured":"Hytiroglou P, Phelps RG, Wattenberg DJ, Strauchen JA (1992) Cytophagic histiocytic panniculitis; molecular evidence for a clonal T cell disorder. J Am Acad Dermatol 27:333\u2013336","journal-title":"J Am Acad Dermatol"},{"key":"8162_CR34","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1191\/096120300678828406","volume":"9","author":"Y Saeki","year":"2000","unstructured":"Saeki Y, Ohshima S, Kurimoto I, Miura H, Suemura M (2000) Maintaining remission of lupus erythematosus profundus (LEP) with cyclosporin A. Lupus 9:390","journal-title":"Lupus"},{"key":"8162_CR35","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0190-9622(81)70129-4","volume":"5","author":"NP Sanchez","year":"1981","unstructured":"Sanchez NP, Peters MS, Winkelmann RK (1981) The histopathology of lupus erythematosus panniculitis. J Am Acad Dermatol 5:673\u2013680","journal-title":"J Am Acad Dermatol"},{"key":"8162_CR36","first-page":"1339","volume":"128","author":"J Lonceint","year":"2001","unstructured":"Lonceint J, Sassolas B, Lefur JM, Guillet G, Leroy JP (2001) Panniculitis and macrophage activation syndrome in a child with lupus erythematosus. Ann Dermatol Venereol 128:1339\u20131342 in French","journal-title":"Ann Dermatol Venereol"},{"key":"8162_CR37","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1191\/096120301669779293","volume":"10","author":"D D'Cruz","year":"2001","unstructured":"D'Cruz D (2001) Antimalarial therapy: a panacea for mild lupus? Lupus 10:148","journal-title":"Lupus"},{"issue":"Suppl 1","key":"8162_CR38","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1177\/0961203396005001051","volume":"5","author":"M Petri","year":"1996","unstructured":"Petri M (1996) Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis. Lupus 5(Suppl 1):S16\u2013S22","journal-title":"Lupus"},{"key":"8162_CR39","unstructured":"Khamashta MA, Wallace DJ (eds) (1996) Antimalarials in rheumatology. Lupus 5(Suppl 1):S1\u2013S73."},{"key":"8162_CR40","first-page":"249","volume":"25","author":"M Easterbrook","year":"1990","unstructured":"Easterbrook M (1990) Is corneal deposition of antimalarial any indication of retinal toxicity? Can J Ophthalmol 25:249\u2013251","journal-title":"Can J Ophthalmol"},{"key":"8162_CR41","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/ard.55.3.187","volume":"55","author":"M Mavrikakis","year":"1996","unstructured":"Mavrikakis M, Papazoglou S, Sifkakis PP, Vaiopoulos G, Rougas K (1996) Retinal toxicity in long term hydroxychloroquine treatment. Ann Rheum Dis 55:187\u2013189","journal-title":"Ann Rheum Dis"},{"key":"8162_CR42","first-page":"2703","volume":"27","author":"D Bienfang","year":"2000","unstructured":"Bienfang D, Coblyn JS, Liang MH, Corzillius M (2000) Hydroxychloroquine retinopathy despite regular ophthalmologic evaluation: a consecutive series. J Rheumatol 27:2703\u20132706","journal-title":"J Rheumatol"},{"key":"8162_CR43","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1346-8138.1989.tb01284.x","volume":"16","author":"Y Yamada","year":"1989","unstructured":"Yamada Y, Dekio S, Jidoi J, Ozasa S (1989) Lupus erythematosus profundus: report of a case treated with dapsone. J Dermatol 16:379\u2013382","journal-title":"J Dermatol"},{"key":"8162_CR44","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1191\/096120301673517315","volume":"10","author":"D Adu","year":"2001","unstructured":"Adu D, Cross J, Jayne DR (2001) Treatment of systemic lupus erythematosus with mycophenolate mofetil. Lupus 10:203\u2013208","journal-title":"Lupus"},{"key":"8162_CR45","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1191\/096120399678840927","volume":"8","author":"M Gaubitz","year":"1999","unstructured":"Gaubitz M, Schorat A, Schotte H, Kern P, Domschke W (1999) Mycophenolate mofetil for the treatment of systemic lupus erythematosus: an open pilot trial. Lupus 8:731\u2013736","journal-title":"Lupus"},{"key":"8162_CR46","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1365-2133.2002.04875.x","volume":"147","author":"S Schanz","year":"2002","unstructured":"Schanz S, Ulmer A, Rassner G, Fierlbeck G (2002) Successful treatment of subacute cutaneous lupus erythematosus with mycophenolate mofetil. Br J Dermatol 147:174\u2013178","journal-title":"Br J Dermatol"},{"key":"8162_CR47","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1067\/mjd.2001.114297","volume":"45","author":"S Goyal","year":"2001","unstructured":"Goyal S, Nousari HC (2001) Treatment of resistant discoid lupus erythematosus of the palms and soles with mycophenolate mofetil. J Am Acad Dermatol 45:142\u2013144","journal-title":"J Am Acad Dermatol"},{"key":"8162_CR48","first-page":"235","volume":"137","author":"I Boehm","year":"2001","unstructured":"Boehm I, Bieber T (2001) Chilblain lupus erythematosus Hutchinson: successful treatment with mycophenolate mofetil. Arch Dermatol 137:235\u2013236","journal-title":"Arch Dermatol"},{"key":"8162_CR49","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1046\/j.1537-2995.2003.00519.x","volume":"43","author":"I Knezevic-Maramica","year":"2003","unstructured":"Knezevic-Maramica I, Kruskall MS (2003) Intravenous immune globulins: an update for clinicians. Transfusion 43:1460\u20131480","journal-title":"Transfusion"},{"key":"8162_CR50","volume-title":"Intravenous immunoglobulin research and therapy","year":"1996","unstructured":"Kazatchkine MD, Morell A (eds) (1996) Intravenous immunoglobulin research and therapy. Parthenon, New York"},{"key":"8162_CR51","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0140-6736(81)92400-4","volume":"1","author":"P Imbach","year":"1981","unstructured":"Imbach P, Barandun S, d\u2019Apuzzo V et al (1981) High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1:1228\u20131231","journal-title":"Lancet"},{"key":"8162_CR52","first-page":"3096","volume":"28","author":"Y Shoenfeld","year":"1996","unstructured":"Shoenfeld Y, Krause I (1996) Immunosuppression and immunomodulation of experimental models of systemic lupus erythematosus and antiphospholipid syndrome. Transplant Proc 28:3096\u20133098","journal-title":"Transplant Proc"},{"key":"8162_CR53","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1537-2995.2006.00792.x","volume":"46","author":"K Darabi","year":"2006","unstructured":"Darabi K, Abdel-Wahab O, Dzik WH (2006) Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature. Transfusion 46:741","journal-title":"Transfusion"},{"key":"8162_CR54","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1442-200X.1995.tb03683.x","volume":"37","author":"Z Onouchi","year":"1995","unstructured":"Onouchi Z, Yanagisawa M, Hirayama T et al (1995) Optimal dosage and differences in therapeutic efficacy of IVIg in Kawasaki disease. Acta Paediatr Jpn 37:40\u201346","journal-title":"Acta Paediatr Jpn"},{"key":"8162_CR55","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1126\/science.291.5503.484","volume":"291","author":"A Samuelsson","year":"2001","unstructured":"Samuelsson A, Towers TL, Ravetch JV (2001) Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 291:484","journal-title":"Science"},{"key":"8162_CR56","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1056\/NEJM198205273062102","volume":"306","author":"J Fehr","year":"1982","unstructured":"Fehr J, Hoffman V, Kappeler U (1982) Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. N Engl J Med 306:1254","journal-title":"N Engl J Med"},{"key":"8162_CR57","first-page":"697","volume":"53","author":"T Tsubakio","year":"1983","unstructured":"Tsubakio T, Kurata Y, Katagiri S et al (1983) Alteration of T cell subsets and immunoglobulin synthesis in vitro during high dose gamma globulin therapy in patients with idiopathic thrombocytopenic purpura. Clin Exp Immunol 53:697","journal-title":"Clin Exp Immunol"},{"key":"8162_CR58","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/0090-1229(92)90044-O","volume":"62","author":"G Dietrich","year":"1992","unstructured":"Dietrich G, Kaveri SV, Kazatchkine MD (1992) Modulation of autoimmunity by intravenous immune globulin through interaction with the function of the immune\/idiotypic network. Clin Immunol Immunopathol 62:S73","journal-title":"Clin Immunol Immunopathol"},{"key":"8162_CR59","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-2249.1991.tb05794.x","volume":"86","author":"SV Kaveri","year":"1991","unstructured":"Kaveri SV, Dietrich G, Hurez V, Kazatchkine MD (1991) Intravenous immunoglobulins (IVIG) in the treatment of autoimmune diseases. Clin Exp Immunol 86:192","journal-title":"Clin Exp Immunol"},{"key":"8162_CR60","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/0140-6736(91)92797-6","volume":"337","author":"DR Jayne","year":"1991","unstructured":"Jayne DR, Davies MJ, Fox CJ et al (1991) Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet 337:1137","journal-title":"Lancet"},{"key":"8162_CR61","first-page":"98","volume":"35","author":"R Palla","year":"1991","unstructured":"Palla R, Cirami C, Panichi V et al (1991) Intravenous immunoglobulin therapy of membranous nephropathy: Efficacy and safety. Clin Nephrol 35:98","journal-title":"Clin Nephrol"},{"key":"8162_CR62","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0022-3476(88)80572-9","volume":"113","author":"S Ashkenazi","year":"1988","unstructured":"Ashkenazi S, Cleary TG, Lopez E, Pickering LK (1988) Anticytotoxin neutralizing antibodies in immune globulin preparations: potential use in hemolytic\u2013uremic syndrome. J Pediatr 113:1008","journal-title":"J Pediatr"},{"key":"8162_CR63","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1182\/blood.V98.10.3136","volume":"98","author":"WK Bleeker","year":"2001","unstructured":"Bleeker WK, Teeling JL, Hack CE (2001) Accelerated autoantibody clearance by intravenous immunoglobulin therapy: studies in experimental models to determine the magnitude and time course of the effect. Blood 98:3136","journal-title":"Blood"},{"key":"8162_CR64","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nm836","volume":"9","author":"M Basta","year":"2003","unstructured":"Basta M, Van Goor F, Luccioli S et al (2003) F(ab)(2)-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins. Nat Med 9:431","journal-title":"Nat Med"},{"key":"8162_CR65","first-page":"133","volume":"62","author":"Y Sherer","year":"2001","unstructured":"Sherer Y, Levy Y, Langevitz P, Rauova L, Fabrizzi F, Shoenfeld Y (2001) Adverse effects of intravenous immunoglobulin therapy in 56 patients with autoimmune diseases. Pharmacolgy 62:133\u2013137","journal-title":"Pharmacolgy"},{"key":"8162_CR66","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1191\/096120301668222237","volume":"10","author":"L Rauova","year":"2001","unstructured":"Rauova L, Lukac J, Levy Y, Rovensky J, Shoenfeld Y (2001) High-dose intravenous immunoglobulins for lupus nephritis\u2014a salvage immunomodulation. Lupus 10:209\u2013213","journal-title":"Lupus"},{"key":"8162_CR67","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.semarthrit.2004.06.003","volume":"34","author":"H Orbach","year":"2004","unstructured":"Orbach H, Tishler M, Shoenfeld Y (2004) Intravenous immunoglobulin and the kidney\u2014a two-edged sword. Semin Arthritis Rheum 34:593\u2013601","journal-title":"Semin Arthritis Rheum"},{"key":"8162_CR68","first-page":"347","volume":"21","author":"AMG Pasatiempo","year":"1994","unstructured":"Pasatiempo AMG, Kroser JA, Rudnick M, Hoffmnann BI (1994) Acute renal failure after intravenous immunoglobulin therapy. J Rheumatol 21:347\u2013349","journal-title":"J Rheumatol"},{"key":"8162_CR69","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0090-1229(89)90082-2","volume":"53","author":"SC Jordan","year":"1989","unstructured":"Jordan SC (1989) Intravenous y-globulin therapy in systemic lupus erythematosus and immune complex disease. Ctin Immunol Immunopathol 53:164\u2013169","journal-title":"Ctin Immunol Immunopathol"},{"key":"8162_CR70","first-page":"673","volume":"14","author":"PJ Hashkes","year":"1996","unstructured":"Hashkes PJ, Lovell DJ (1996) Vasculitis in systemic lupus erythematosus following intravenous immunoglobulin therapy. Clin Exp Rheumatol 14:673\u2013675","journal-title":"Clin Exp Rheumatol"},{"key":"8162_CR71","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/0140-6736(92)90806-E","volume":"339","author":"WH Reinhart","year":"1992","unstructured":"Reinhart WH, Berchtold PE (1992) Effect of high-dose intravenous immunoglobulin therapy on blood rheology. Lancet 339:662\u2013644","journal-title":"Lancet"},{"key":"8162_CR72","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1212\/WNL.44.2.223","volume":"44","author":"MC Dalakas","year":"1994","unstructured":"Dalakas MC (1994) High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events. Neurology 44:223\u2013226","journal-title":"Neurology"},{"key":"8162_CR73","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1046\/j.1442-200X.2003.01677.x","volume":"45","author":"M Nishikawa","year":"2003","unstructured":"Nishikawa M, Ichiyama T, Hasegawa M, Kawasaki K, Matsubara T, Furukawa S (2003) Safety from thromboembolism using intravenous immunoglobulin therapy in Kawasaki disease: study of whole-blood viscosity. Pediatr Int 45:156\u2013158","journal-title":"Pediatr Int"},{"key":"8162_CR74","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(86)92511-0","volume":"2","author":"RK Woodruff","year":"1986","unstructured":"Woodruff RK, Grigg AP, Firkin FC, Smith IL (1986) Fatal thrombotic events during treatment of autoimmune thrombocytopenia with intravenous immunoglobulin in elderly patients. Lancet 2:217\u2013218","journal-title":"Lancet"},{"key":"8162_CR75","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.46.1.250","volume":"46","author":"R Voltz","year":"1996","unstructured":"Voltz R, Rosen FV, Yousry T, Beck J, Hohlfeld R (1996) Reversible encephalopathy with cerebral vasospasm in a Guillain\u2013Barre syndrome patient treated with intravenous immunoglobulin. Neurology 46:250\u2013251","journal-title":"Neurology"},{"key":"8162_CR76","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000008040","volume":"41","author":"R Sztajzel","year":"1999","unstructured":"Sztajzel R, Le Floch-Rohr J, Eggimann P (1999) High-dose intravenous immunoglobulin treatment and cerebral vasospasm: a possible mechanism of ischemic encephalopathy? Eur Neurol 41:153\u2013158","journal-title":"Eur Neurol"},{"key":"8162_CR77","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1191\/0961203303lu2168rr","volume":"14","author":"U Katz","year":"2005","unstructured":"Katz U, Shoenfeld Y (2005) Review: intravenous immunoglobulin therapy and thromboembolic complications. Lupus 14:802","journal-title":"Lupus"},{"key":"8162_CR78","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4065\/75.1.83","volume":"75","author":"RS Go","year":"2000","unstructured":"Go RS, Call TG (2000) Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: case report and literature review of intravenous immunoglobulin-related thrombotic complications. Mayo Clin Proc 75:83\u201385","journal-title":"Mayo Clin Proc"},{"key":"8162_CR79","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1136\/jnnp.68.6.790","volume":"68","author":"B Turner","year":"2000","unstructured":"Turner B, Wills AJ (2000) Cerebral infarction complicating intravenous immunoglobulin therapy in a patient with Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 68:790\u2013791","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8162_CR80","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1023\/B:JOCI.0000019809.55787.ec","volume":"24","author":"Y Shoenfeld","year":"2004","unstructured":"Shoenfeld Y, Krause I (2004) IVIG for autoimmune, fibrosis, and malignant conditions: our experience with 200 patients. J Clin Immunol 24:107\u2013114","journal-title":"J Clin Immunol"},{"key":"8162_CR81","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1191\/096120301701549705","volume":"10","author":"Y Sherer","year":"2001","unstructured":"Sherer Y, Wu R, Krause I, Peter JB, Shoenfeld Y (2001) Antiphospholipid antibody levels in intravenous immunoglobulin (IVIg) preparations. Lupus 10:568. doi: 10.1191\/096120301701549705","journal-title":"Lupus"},{"key":"8162_CR82","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1023\/A:1023239904856","volume":"18","author":"I Krause","year":"1998","unstructured":"Krause I, Blank M, Shoenfeld Y (1998) Anti-DNA and antiphospholipid antibodies in IVIg preparations: in vivo study in naive mice. J Clin Immunol 18:52\u201360","journal-title":"J Clin Immunol"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-009-8162-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-009-8162-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-009-8162-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T21:12:17Z","timestamp":1633641137000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-009-8162-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,27]]},"references-count":82,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["8162"],"URL":"https:\/\/doi.org\/10.1007\/s12016-009-8162-x","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,27]]}}}